Do Pharmaceutical Patents Generate Unique Global Health Duties?
Publication Date
12-12-2019
Document Type
Article
Organizational Units
Sturm College of Law
Keywords
Pharmaceutics, Patents, Global health, Intellectual property
Abstract
Imagine a Harvard MBA graduate trying to decide between jobs at Pfizer and at Snapchat. Both are immensely wealthy firms. Many of Pfizer’s products benefit global health. Snapchat’s are at best neutral and may even harm health. Yet many see Pfizer as distinctively culpable for global health deficits. These arguments often depend on the fact that Pfizer holds intellectual property (IP) in pharmaceuticals, whereas Snapchat holds cash and non-pharmaceutical IP.
Copyright Statement / License for Reuse
All Rights Reserved.
Publication Statement
User is responsible for all copyright compliance.
Recommended Citation
Govind Persad, Do Pharmaceutical Patents Generate Unique Global Health Duties?, Bill of Health (Dec. 12, 2019), https://blog.petrieflom.law.harvard.edu/2019/12/12/pharmaceutical-patents-global-health-ethics-ip/.